Docoh
Loading...

IFRX InflaRx

Filed: 3 May 21, 4:15pm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 6-K



Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
 
For the month of May, 2021
 
Commission File Number: 001-38283


 
InflaRx N.V.
(Translation of registrant's name into English)


 
Winzerlaer Str. 2
07745 Jena, Germany
(Address of principal executive office)


 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F ☒        Form 40-F ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐



INFLARX N.V.
 
On May 3, 2021, InflaRx N.V. convened the annual general meeting of shareholders to be held on May 19, 2021 and made available to its shareholders certain other materials in connection with such meeting.
 
Such materials are attached as exhibits to this Form 6-K and are incorporated by reference herein.


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 INFLARX N.V.
   
Date: May 3, 2021
By:
/s/ Niels Riedemann

Name:
Niels Riedemann

Title:
Chief Executive Officer


EXHIBIT INDEX
 
Exhibit No.
 
Description
 
Convening Notice, including Agenda and Explanatory Notes
 
Voting Proxy